{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:30:19Z","timestamp":1761532219770,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.brachy.2021.11.002","type":"journal-article","created":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T07:35:39Z","timestamp":1640936139000},"page":"202-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Can we reduce dose to ureters as avoidance organs for MRI based brachytherapy for cervical cancer? A dosimetric feasibility study"],"prefix":"10.1016","volume":"21","author":[{"given":"Sean A.","family":"Koerner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanvir","family":"Baig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4930-3363","authenticated-orcid":false,"given":"Joshua","family":"Rodr\u00edguez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil","family":"Beriwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2015","series-title":"Global Cancer Facts & Figures","key":"10.1016\/j.brachy.2021.11.002_bib0001"},{"key":"10.1016\/j.brachy.2021.11.002_bib0002","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ypmed.2019.04.010","article-title":"Trends in cervical cancer incidence rates by age, race\/ethnicity, histological subtype, and stage at diagnosis in the United States","volume":"123","author":"Islami","year":"2019","journal-title":"Prev Med"},{"issue":"5","key":"10.1016\/j.brachy.2021.11.002_bib0003","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/AOG.0b013e3181f74062","article-title":"Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type","volume":"116","author":"Reynolds","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.brachy.2021.11.002_bib0004","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1159\/000448794","article-title":"Surgical treatment of early-stage cervical cancer","volume":"39","author":"Brucker","year":"2016","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.brachy.2021.11.002_bib0005","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brachy.2021.11.002_bib0006","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1200\/JCO.2004.07.197","article-title":"Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90\u201301","volume":"22","author":"Eifel","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2021.11.002_bib0007","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/0360-3016(95)00177-Z","article-title":"Carcinoma of the cervix: patterns of care studies: review of 1978, 1983, and 1988\u20131989 surveys","volume":"32","author":"Montana","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.11.002_bib0008","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0360-3016(91)90007-Q","article-title":"Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies","volume":"20","author":"Lanciano","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.11.002_bib0009","first-page":"555","article-title":"Brachytherapy in the treatment of cervical cancer: a review","volume":"6","author":"Banerjee","year":"2014","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.brachy.2021.11.002_bib0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2014.08.027","article-title":"Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy","volume":"135","author":"Rijkmans","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2021.11.002_bib0011","doi-asserted-by":"crossref","first-page":"921","DOI":"10.5306\/wjco.v5.i5.921","article-title":"Image-based brachytherapy for cervical cancer","volume":"5","author":"Vargo","year":"2014","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.brachy.2021.11.002_bib0012","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3109\/0284186X.2013.818253","article-title":"MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective","volume":"52","author":"Lindegaard","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.brachy.2021.11.002_bib0013","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1634\/theoncologist.2012-0367","article-title":"Adaptive 3D image-guided brachytherapy: a strong argument in the debate on systematic radical hysterectomy for locally advanced cervical cance","volume":"18","author":"Mazeron","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.brachy.2021.11.002_bib0014","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.ijrobp.2008.09.010","article-title":"Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix","volume":"74","author":"Zwahlen","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.11.002_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.radonc.2013.04.006","article-title":"Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience","volume":"107","author":"Nomden","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2021.11.002_bib0016","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.radonc.2016.03.020","article-title":"Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: analysis from the retroEMBRACE study","volume":"120","author":"Fokdal","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2021.11.002_bib0017","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jjco\/hys010","article-title":"CT or MRI for image-based brachytherapy in cervical cancer","volume":"42","author":"Krishnatry","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.brachy.2021.11.002_bib0018","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0022-5347(01)64325-8","article-title":"Late urological complications and malignancies after curative radiotherapy for gynecological carcinomas: a retrospective analysis of 10,709 patients","volume":"158","author":"Maier","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2021.11.002_bib0019","unstructured":"Same-institution author, 2020. Censored to preserve blind review."},{"key":"10.1016\/j.brachy.2021.11.002_bib0020","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.brachy.2021.03.007","article-title":"Feasibility of ureter delineation and dose recording in the assessment of ureteric stenosis during brachytherapy for cervical cancer","volume":"20","author":"Sarwar","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2021.11.002_bib0021","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ijrobp.2018.11.006","article-title":"Risk Factors for Ureteral Stricture After Radiochemotherapy Including Image Guided Adaptive Brachytherapy in Cervical Cancer: results From the EMBRACE Studies","volume":"103","author":"Fokdal","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.11.002_bib0022","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5114\/jcb.2011.21038","article-title":"Prophylactic urethral stenting with Memokath\u00ae 028SW in prostate cancer patients undergoing prostate 125I seed implants: phase I\/II study","volume":"3","author":"Chao","year":"2011","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2021.11.002_bib0023","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.brachy.2017.05.011","article-title":"Total reference air kerma can accurately predict isodose surface volumes in cervix cancer brachytherapy. A multicenter study","volume":"16","author":"Nkiwane","year":"2017","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.brachy.2021.11.002_bib0024","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brachy.2015.09.002","article-title":"Hybrid (CT\/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: dosimetry comparisons and clinical outcome","volume":"15","author":"Choong","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2021.11.002_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.brachy.2021.03.007","article-title":"Feasibility of ureter delineation and dose recording in the assessment of ureteric stenosis during brachytherapy for cervical cancer","author":"Sarwar","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2021.11.002_bib0026","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/IGC.0b013e3181c4a627","article-title":"Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring","volume":"20","author":"Eskander","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2021.11.002_bib0027","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/jcm8010125","article-title":"Total reference air kerma is associated with late bowel morbidity in locally advanced cervical cancer patients treated with image-guided adaptive brachytherapy","volume":"8","author":"Bockel","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.brachy.2021.11.002_bib0028","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.radonc.2015.12.025","article-title":"Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study","volume":"118","author":"Kirchheiner","year":"2016","journal-title":"Radiother Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472121005328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472121005328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:17:33Z","timestamp":1761531453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472121005328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1538472121005328"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2021.11.002","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can we reduce dose to ureters as avoidance organs for MRI based brachytherapy for cervical cancer? A dosimetric feasibility study","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2021.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}